Meningococcal Polysaccharide Vaccine Dosage

Medically reviewed on December 14, 2016.

Usual Adult Dose for Meningococcal Meningitis Prophylaxis

0.5 mL, subcutaneously, once

Usual Pediatric Dose for Meningococcal Meningitis Prophylaxis

2 years and older:
0.5 mL, subcutaneously, once

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dose Adjustments

-The ACIP has recommendations for revaccination of high risk patients.
-If used for revaccination, the dose is 0.5 mL, subcutaneously.

Precautions

Safety and efficacy have not been established in patients younger than 2 years.

To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS) at: https://vaers.hhs.gov

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
-Do not administer IV or IM.
-The deltoid region is the preferred administration site.
-Single dose vials should be used immediately after reconstitution.
-Multidose vials may be used for up to 35 days after reconstitution if stored at 35 to 46F.

Storage requirements:
-Refrigerate; do not freeze.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer